MRNS - Marinus Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 593.59M
Enterprise Value 340.44M
Trailing P/E N/A
Forward P/E 1-2.22
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.01
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.89

Trading Information

Stock Price History

Beta (3Y Monthly) 3.31
52-Week Change 3-75.86%
S&P500 52-Week Change 34.11%
52 Week High 310.5400
52 Week Low 30.7700
50-Day Moving Average 31.2709
200-Day Moving Average 33.4081

Share Statistics

Avg Vol (3 month) 31.2M
Avg Vol (10 day) 31.33M
Shares Outstanding 552.58M
Float 43.75M
% Held by Insiders 10.92%
% Held by Institutions 172.27%
Shares Short (Aug 15, 2019) 43.5M
Short Ratio (Aug 15, 2019) 42.16
Short % of Float (Aug 15, 2019) 46.72%
Short % of Shares Outstanding (Aug 15, 2019) 46.66%
Shares Short (prior month Jul 15, 2019) 43.76M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-52.88%
Return on Equity (ttm)-100.71%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -45.37M
Net Income Avi to Common (ttm)-46.13M
Diluted EPS (ttm)-0.9820
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)51.92M
Total Cash Per Share (mrq)0.99
Total Debt (mrq)3.5M
Total Debt/Equity (mrq)7.51
Current Ratio (mrq)5.89
Book Value Per Share (mrq)0.89

Cash Flow Statement

Operating Cash Flow (ttm)-36.34M
Levered Free Cash Flow (ttm)-19.22M